OC.06.6: Therapeutic Drug Monitoring of Infliximab for the Management of Loss of Response in Inflammatory Bowel Disease: An Observational Multicenter Study. (15th March 2017) - Guidi, L.; Pugliese, D.; Panici Tonucci, T.; Tolusso, B.; Cantoro, L.; Kohn, A.; Balestrieri, P.; Cicala, M.; Civitelli, F.; Viola, F.; Bertani, L.; Costa, F.; et al.